Table of Contents Author Guidelines Submit a Manuscript
Prostate Cancer
Volume 2019, Article ID 8107807, 14 pages
https://doi.org/10.1155/2019/8107807
Research Article

The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour’s TMPRSS2-ERG Fusion Status

1Philips Research Europe, 5656AE Eindhoven, Netherlands
2Gerhard-Domagk-Institute of Pathology, University Hospital Münster, 48149 Münster, Germany
3Prostate Center, University Hospital Münster, 48149 Münster, Germany
4Institute of Cardiovascular and Medical Science, University of Glasgow, G12 8TA Glasgow, Scotland, UK
5Institute of Pharmaceutical Science, King’s College London, 150 Stamford Street, London, WC2R 2LS London, UK
6Mironid Ltd, BioCity Scotland, ML1 5UH Newhouse, Scotland, UK
7Department of Urology, 3000CA Erasmus Medical Center, Rotterdam, Netherlands

Correspondence should be addressed to Ralf Hoffmann; moc.spilihp@nnamffoh.flar

Received 27 January 2019; Revised 10 April 2019; Accepted 21 April 2019; Published 2 June 2019

Guest Editor: Anna Ferrari

Copyright © 2019 Dianne van Strijp et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Dianne van Strijp, Christiane de Witz, Birthe Heitkötter, et al., “The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour’s TMPRSS2-ERG Fusion Status,” Prostate Cancer, vol. 2019, Article ID 8107807, 14 pages, 2019. https://doi.org/10.1155/2019/8107807.